Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Holders of 5% or more of CDAK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Codiak BioSciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Codiak BioSciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Codiak BioSciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Apr 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Mar 3, 2023 | Laurion Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Flagship Ventures Fund V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Laurion Capital Management LP | 13GOld format | – | New | – | SEC |
| Sep 20, 2022 | ARCH Venture Fund VIII, L.P. | 13DOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Flagship Ventures Fund V, L.P. | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Alaska Permanent Fund Corp | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2021 | ARCH Venture Fund VIII, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Codiak BioSciences, Inc. shares.
No Form 144 notices for Codiak BioSciences, Inc. are on file.